BeStock  

Evotec EVO

US equityMarket cap rank #3654Drug Manufacturers - Specialty & Generic
$1.61 −$0.02 (-1.23%)
Pre-market · Oct 8, 9:00 am ET · After hours $1.61 0.00%
Open$1.60
Prev close$1.63
Day range$1.58 – $1.63
Volume93.1K
Market cap$572.18M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026 · reported in EUR

Revenue€143.48M-16.2% YoY
Operating profit-€89.32M-212.3% YoY
Net profit-€46.65M-7.3% YoY
Diluted EPS-€0.13-9.7% YoY
Free cash flow-€118.20M-4,484.3% YoY
Operating cash flow-€107.19M

Revenue, last 8 quarters

€184.9MSep '24€221.2MDec '24€200.0MMar '25€171.2MJun '25€163.9MSep '25€253.3MDec '25€156.6MMar '26€143.5MJun '26

Net profit, last 8 quarters

€-39.6MSep '24€-40.8MDec '24€-31.6MMar '25€-43.5MJun '25€-43.1MSep '25€14.6MDec '25€-121.9MMar '26€-46.6MJun '26

Diluted EPS by quarter

-0.11Sep '24-0.12Dec '24-0.09Mar '25-0.12Jun '25-0.12Sep '250.05Dec '25-0.35Mar '26-0.13Jun '26

Free cash flow by quarter

€14.3MSep '24€49.1MDec '24€-53.6MMar '25€2.7MJun '25€-89.0MSep '25€48.1MDec '25€-14.7MMar '26€-118.2MJun '26

Annual revenue

€500.9MFY20€618.0MFY21€751.4MFY22€781.4MFY23€797.0MFY24€788.4MFY25

Profitability & balance sheet

Gross margin8.5%
Operating margin-20.0%
Net margin-27.5%
Return on equity-26.1%
Return on assets-11.7%
Return on invested capital-15.3%
Current ratio2.33
Liabilities / assets57.7%
Cash & investments€483.62M
Total debt€414.32M
Net cash (debt)€69.30M

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Discovery & Preclinical Development (D&PD)€119.90M 76.5%
  • Just - Evotec Biologics (JEB)€36.84M 23.5%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Revenue as Reported €143.48M €156.64M €788.37M €253.27M €163.89M
Total Operating Revenue €143.48M €156.64M €788.37M €253.27M €163.89M
Cost of Revenue €145.06M €158.21M €674.15M €174.81M €163.95M
Gross Profit -€1.58M -€1.57M €114.22M €78.46M -€62,000.00
Operating Expense €87.74M €44.85M €170.04M €41.26M €44.55M
Selling and Admin Expenses €39.29M €43.79M €175.97M €44.35M €42.31M
Research & Development €10.26M €10.08M €37.51M €9.83M €8.71M
Other Operating Expenses €38.20M -€9.02M -€1.83M €28.69M -€6.48M
Operating Profit -€89.32M -€46.42M -€55.82M €37.21M -€44.61M
Net Non-Operating Interest Income (Expense) -€2.79M -€790,000.00 -€10.02M -€2.60M -€1.44M
Non-Operating Interest Income €183,000.00 €1.79M €4.42M €1.16M €841,000.00
Non-Operating Interest Expense €2.97M €2.58M €14.44M €3.76M €2.28M
Other Income (Expense) €43.99M -€74.97M -€20.93M -€5.15M €3.09M
Gain on Sale of Security €69.84M €192,000.00 -€677,000.00 -€2.42M €1.31M
Earnings from Equity Interest -€869,000.00 -€286,000.00 -€1.09M -€349,000.00 €480,000.00
Special Income (Charges) -€23.95M -€74.97M -€399,000.00 -€1.14M €108,000.00
-Less:Restructuring and Mergern & Acquisition €23.95M €74.97M €633,000.00 €1.37M -€108,000.00
Other Non-Operating Income (Expenses) -€1.02M €100,000.00 -€18.77M -€1.24M €1.19M
Pretax Profit -€48.12M -€122.18M -€86.77M €29.46M -€42.96M
Tax -€1.47M -€244,000.00 €16.75M €14.84M €127,000.00
Net Profit -€46.65M -€121.94M -€103.52M €14.62M -€43.09M
Profit from Continuing Operations -€46.65M -€121.94M -€103.52M €14.62M -€43.09M
Net Income to Parent Company -€46.65M -€121.94M -€103.52M €14.62M -€43.09M
Net Income to Common Stockholders -€46.65M -€121.94M -€103.52M €14.62M -€43.09M
Basic EPS -€0.13 -€0.34 -€0.29 €0.05 -€0.12
Diluted EPS -€0.13 -€0.35 -€0.29 €0.05 -€0.12
-Selling & Marketing Expense – – €17.38M – –
-General & Admin Expense – – €158.60M – –
Other Taxes – – -€41.61M – –
-Less:Impairment of Capital Assets – – €0.00 – –
-Less:Other Special Charges – – €1.68M – –
-Gain on Sale Of Business – – €1.91M – –

Balance sheet

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Total Assets €1.57B €1.64B €1.71B €1.71B €1.77B
Total Current Assets €728.89M €711.28M €762.95M €762.95M €793.12M
Cash and Cash Equivalents & Short-Term Investments €483.62M €463.78M €463.02M €463.02M €242.80M
-Cash and Cash Equivalents €348.36M €387.91M €401.79M €401.79M €174.04M
-Short Term Investments €135.26M €75.87M €61.23M €61.23M €68.76M
Receivables €166.46M €167.05M €213.51M €213.51M €192.65M
-Accounts Receivable €96.35M €98.26M €135.96M €135.96M €103.77M
-Taxes Receivable €36.82M €33.47M €49.25M €49.25M €36.97M
-Other Receivables €33.29M €35.32M €28.30M €28.30M €51.92M
Inventory €38.56M €32.98M €29.32M €29.32M €31.18M
Other Current Assets €40.25M €43.55M €709,000.00 €709,000.00 €45.02M
Total Non-Current Assets €845.09M €928.53M €951.00M €951.00M €979.59M
Net PPE €449.77M €530.84M €554.63M €554.63M €565.23M
Investments and Advances €42.55M €53.31M €52.63M €52.63M €50.02M
-Available for Sale Securities €39.07M €48.97M €48.00M €48.00M –
-Long Term Equity Investment €3.48M €4.35M €4.63M €4.63M €4.98M
Non Current Accounts Receivables €43.27M €36.87M €36.35M €36.35M €51.90M
Goodwill and Other Intangible Assets €306.51M €305.41M €303.94M €303.94M €300.56M
Non-Current Deferred Assets €1.89M €1.69M €2.95M €2.95M €11.12M
Other Non-Current Assets €1.10M €417,000.00 €508,000.00 €508,000.00 €761,000.00
Total Liabilities €908.40M €940.19M €900.24M €900.24M €972.56M
Total Current Liabilities €312.46M €423.37M €368.07M €368.07M €374.47M
Payables €58.03M €64.42M €81.03M €81.03M €56.51M
-Accounts Payable €49.13M €54.90M €64.76M €64.76M €49.49M
-Total Tax Payable €8.90M €9.52M €16.27M €16.27M €7.02M
Short-Term Debt and Capital Lease Obligation €61.54M €88.62M €103.68M €103.68M €96.87M
Current Provisions €92.76M €130.83M €58.54M €58.54M €43.35M
Current Deferred Liabilities €72.53M €114.69M €108.07M €108.07M €109.71M
Other Current Liabilities €27.60M €24.83M €11.10M €11.10M €68.03M
Total Non-Current Liabilities €595.94M €516.82M €532.17M €532.17M €598.10M
Long Term Debt and Capital Lease Obligation €414.32M €298.85M €344.01M €344.01M –
-Long Term Debt €414.32M €298.85M €344.01M €344.01M –
Non-Current Liabilities €26.23M €64.17M €18.04M €18.04M €18.25M
Non-Current Deferred Liabilities €154.05M €152.46M €168.41M €168.41M €192.11M
Other Non-Current Liabilities €1.34M €1.34M €1.72M €1.72M €387.74M
Total Equity €665.58M €699.62M €813.70M €813.70M €800.14M
Stockholders' Equity €665.58M €699.62M €813.70M €813.70M €800.14M
Capital Stock €177.91M €177.88M €177.78M €177.78M €177.77M
-Common Stock €177.91M €177.88M €177.78M €177.78M €177.77M
Additional Paid-In Capital €1.47B €1.46B €1.46B €1.46B €1.46B
Retained Earnings -€944.47M -€897.82M -€775.89M -€775.89M -€790.51M
Less: Treasury Stock €980,000.00 €1.14M €1.55M €1.55M –
Gains/Losses Not Affecting Retained Earnings -€35.77M -€38.32M -€45.11M -€45.11M -€47.17M
Other Equity Interests -€1,000.00 – – – -€1,000.00
Prepaid Assets – – €18.97M €18.97M –
Restricted Cash – – €33.59M €33.59M –
-Gross PPE – – €1.07B €1.07B –
-Accumulated Depreciation – – -€519.54M -€519.54M –
-Goodwill – – €272.37M €272.37M –
-Other Intangible Assets – – €31.57M €31.57M –
-Current Debt – – €81.50M €81.50M –
-Current Capital Lease Obligation – – €22.18M €22.18M –

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Operating Cash Flow -€107.19M -€3.92M -€9.18M €63.63M -€67.56M
Net cash flow from continuing operations -€107.19M -€3.92M -€9.18M €63.63M -€67.56M
Net Income from Continuing Operations -€46.65M -€121.94M -€103.52M €14.62M -€43.09M
Other Non-Cash Items €22.88M €46.53M €28.99M -€83.42M €71.73M
Change in Working Capital -€83.42M €71.49M -€60.80M €6.27M -€96.20M
Net cash flow from investing €19.52M -€12.43M €171.59M €222.38M -€7.24M
Net Cash Flow from Continuing Investing Activities €19.52M -€12.44M €171.59M €222.38M -€7.24M
Net PPE Purchase and Sale -€9.11M -€4.08M -€72.33M -€14.51M -€20.21M
Net Intangibles Purchase and Sale -€1.90M -€6.63M -€10.08M -€824,000.00 -€1.20M
Net Business Purchase and Sale -€2.27M -€4.50M €216.86M €231.38M -€4.86M
Net Investment Purchase and Sale €30.52M €905,000.00 €31.97M €5.48M €17.17M
Net Other Investing Changes -€2,000.00 €1,000.00 €1,000.00 – –
Financing Cash Flow €52.86M -€19.09M -€37.63M -€46.23M -€12.13M
Net Cash Flow from Continuing Financing Activities €52.86M -€19.09M -€37.63M -€46.23M -€12.13M
Net Issuance Payments Of Debt €55.75M -€19.09M -€29.42M -€43.80M -€9.83M
Cash Dividends Paid €0.00 €0.00 €0.00 €0.00 €0.00
Proceeds from Stock Option Exercised €32,000.00 €99,000.00 €225,000.00 €7,000.00 €5,000.00
Ending Cash Balance €348.36M €387.91M €418.52M €418.52M €179.27M
Net Change in Cash -€34.81M -€35.44M €124.78M €239.78M -€86.93M
Beginning Cash Balance €387.91M €418.52M €306.39M €179.27M €267.83M
Effect of Exchange Rate Changes -€4.75M €4.84M -€12.65M -€539,000.00 -€1.62M
Free Cash Flow -€118.20M -€14.70M -€91.80M €48.11M -€88.96M
Net Other Financing Charges – -€1,000.00 -€1.46M -€99,000.00 -€1.37M
Gain/Loss from Continuing Operations – – -€7.29M – –
Depreciation & Depletion & Amortization – – €99.48M – –
Deferred Tax – – €16.75M – –
-Change in Receivables – – -€28.73M – –
-Change in Inventory – – -€9.56M – –
-Change in Payables and Accrued Expense – – -€7.30M – –
-Change In Other Working Capital – – -€15.21M – –
Net Common Stock Issuance – – -€1.55M – –

Discussion

No comments yet — be the first to weigh in on EVO.

Leave a comment

Scroll to Top